Dr. Randall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8550 Datapoint Dr
Suite 200
San Antonio, TX 78229Phone+1 210-615-8308Fax+1 210-615-8313
Summary
- Dr. Charles Randall is a gastroenterologist in San Antonio, TX and is affiliated with multiple hospitals in the area, including Methodist Hospital, Kindred Hospital-San Antonio, and PAM Specialty Hospital of San Antonio Center. He received his medical degree from University of Texas Medical Branch School of Medicine and has been in practice 29 years. He is experienced in crohn's disease and interventional gastroenterology. He has more than 10 publications and over 450 citings.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Gastroenterology, 1991 - 1993
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1988 - 1991
- University of Texas Medical Branch School of MedicineClass of 1988
Certifications & Licensure
- TX State Medical License 1990 - 2026
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease Start of enrollment: 2013 Mar 01
- Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) Start of enrollment: 2016 May 19
Publications & Presentations
PubMed
- 23 citationsClinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiS...W J Sandborn, Gil Y. Melmed, Dermot P.B. McGovern, Edward V. Loftus, J. M. Choi
Alimentary Pharmacology & Therapeutics. 2015-08-01 - 219 citationsInfliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic ResectionMiguel Regueiro, Brian G. Feagan, Bin Zou, Jewel Johanns, Marion Blank
Gastroenterology. 2016-06-01 - 6 citationsReinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.Scott D. Lee, David T. Rubin, William J. Sandborn, Charles Randall, Ziad Younes
Inflammatory Bowel Diseases. 2016-08-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: